ICB/FW/EPSA6/GF-HAPCO/NFMIII/ARV/OI/PH/03/22
August 5, 2022
Tender Code: ICB/FW/EPSA6/GF-HAPCO/NFMIII/ARV/OI/PH/03/22
Award Status: Full Winners List
Award Date: 08/05/2022
Tender Award: Download
Unsuccessful Bidders:
Technical Evaluation Result:
|
|
Company Name: | Document No: OF/TM/ HO-14 | ||||||||||||||||
| የኢትዮጵያመድሃኒትአቅራቢኤጀንሲ | ||||||||||||||||||
| Ethiopian Pharmaceuticals Supply Agency | ||||||||||||||||||
| Title: | Effective date : 13/09/2019 | |||||||||||||||||
| Official winner list | Rev. No.: 0 | |||||||||||||||||
| Official winner list of tender No : ICB/FW/EPSA6/GF-HAPCO/NFMIII/ARV/OI/PH/03/22 | ||||||||||||||||||
| Item No. | Description | offered pack size/unit | Estimated total Quantity with winner pack size | No of bidders to be awarded | Winner | Currency | Unit FOB price | Allocated volume | Payment Term | Port of shipment | Delivery Time | Remark | ||||||
| Supplier | Country | |||||||||||||||||
| 1 | Abacavir (ABC) – 300mg – Tablet | 60 | 396,800 | 2 | Aurobindo Pharma Limited | India | USD | 6.90 | 238,080 | L/C | Hyderabad | Within 60- 90 days from L/C opening date | winner price | |||||
| Hetro Labs Limited | India | USD | 6.93 | 158,720 | L/C | Mumbai | Within 60- 90 days from L/C opening date | 2nd Least price | ||||||||||
| 2 | Abacavir (ABC) + Lamivudine (3TC) – (120mg + 60mg) – Tablet | 60 | 455,450 | 2 | Cipla Limited | India | USD | 6.25 | 455,450 | LC | Mumbai | Within 60- 90 days from L/C opening date | winner price | |||||
| 4 | Atazanavir (ATV) + Ritonavir (RTV) – (300mg +100mg) – Tablet | 30 | 1,183,516 | 3 | Emcure Pharmaceuticals LTD | India | USD | 13.4 | All | L/C | Mumbai | Within 60- 90 days from L/C opening date for consecutive orders | winner price | |||||
| 5 | Darunavir (DRV) – 600mg – Tablet | 60 | 50,294 | 2 | Hetro Labs Limited | India | USD | 41 | 30,176 | L/C | Mumbai | Within 60- 90 days from L/C opening date | winner price | |||||
| Cipla Limited | India | USD | 46.00 | 20,118 | L/C | Mumbai | Within 60- 90 days from L/C opening date for consecutive orders | 2nd Least price | ||||||||||
| 9 | Efavirenz (EFV) – 600mg – Tablet | 30 | 125,972 | 1 | Micro Labs Limited | India | USD | 2.395 | All | L/C | Mumbai | Within 60- 90 days from L/C opening date for consecutive orders | Winner price | |||||
| 11 | Lamivudine (3TC) + Dolutegravir (DTG) + Tenofovir (TDF) – (300mg + 50mg + 300mg) – Tablet | 30 | 2,553,493 | 3 | Macleods Pharmaceuticals Ltd | India | USD | 3.58 | 1,532,096 | L/C | Mumbai | Within 60-90 days after L/C opening date | winner price | |||||
| Laurus Labs Limited | India | USD | 3.78 | 638,373 | L/C | Mumbai /Hyderabad | Within 60 – 90 days after L/C opening date | 2nd least price | ||||||||||
| Hetro Labs Limited | India | USD | 3.78 | 383,024 | L/C | Mumbai | Within 60 – 90 days after L/C opening date | 3rd least price | ||||||||||
| 12 | Lamivudine + Tenofovir – (300mg + 300mg) – Tablet | 30 | 971,468 | 3 | Macleods Pharmaceuticals Ltd | India | USD | 2.71 | 582,881 | L/C | Mumbai | With in 60-90 days after L/C opening date | winner price | |||||
| Hetro Labs Limited | India | USD | 2.900 | 242,867 | L/C | Mumbai | Within 60- 90 days from L/C opening date for consecutive orders | 2nd least price | ||||||||||
| Micro Labs Limited | India | USD | 3.360 | 145,720 | L/C | Mumbai | Within 60- 90 days from L/C opening date for consecutive orders | 3rd least price | ||||||||||
| 14 | Lamivudine + Zidovudine – (30mg + 60mg) – Tablet | 60 | 145,565 | 1 | Micro Labs Limited | India | USD | 1.740 | All | L/C | Mumbai | Within 60- 90 days from L/C opening date for consecutive orders | winner price | |||||
| 15 | Lopinavir + Ritonavir – (100mg + 25mg) – Tablet | 120 | 7,146 | 2 | Cancelled | |||||||||||||
| 16 | Lopinavir + Ritonavir – (200mg + 50mg) – Tablet | 120 | 212,623 | 2 | Aurobindo Pharma Limited | India | USD | 16.20 | 127,574 | L/C | Hyderabad | Wthin 60 – 90 days after L/C opening date | winner price | |||||
| Laurus Labs Limited | India | USD | 21.50 | 85,049 | L/C | Hyderabad-Air Mumbai-sea | Wthin 60 – 90 days after L/C opening date | 2nd least price | ||||||||||
| 19 | Ritonavir (RTV) – 100mg – Tablet | 30 | 101,356 | 2 | Hetro Labs Limited | India | USD | 7.00 | All | L/C | Mumbai | Within 60- 90 days from L/C opening date | winner price | |||||
| 20 | Sulphamethoxazole + Trimethoprim – (200mg + 40mg)/5ml – Suspension | 100 ml | 541,647 | 2 | Leben Laboratories Pvt.Ltd | India | USD | 0.28 | 324,988 | L/C | NHAVA SHEVA Mumbai | Within 90 days from L/C opening date | winner price | |||||
| Unique Pharmaceutical Laboratories | India | USD | 0.285 | 216,659 | L/C | JNPT NHAVA SHEVA Mumbai | Within 90 days from date of receipt of L/C at sight | 2nd least price | ||||||||||
| 22 | Sulphamethoxazole + Trimethoprim – (800 mg + 160 mg) – Tablet | 100×10 | 138,096 | 2 | Milan Laboratories | India | USD | 20.00 | 82,858 | L/C | JNPT port,/ Mumbai | Within 90 days after L/C opening date | winner price | |||||
| Leben Laboratories Pvt.Ltd | India | USD | 21.96 | 55,238 | L/C | NHAVA SHEVA Mumbai | Within 90 days from L/C opening date | 2nd least price | ||||||||||
| እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | OF for Official winner list OF/TM/HO-14 0, 13/09/2019 | |||||||||||||||||
| Make sure that this is the correct issue before use | ||||||||||||||||||
Reasons for Rejection
|
|
Company Name: | Document No: OF/TM/ HO-17 | ||||
| የኢትዮጵያ መድሃኒት አቅራቢ ኤጀንሲ | ||||||
| Ethiopian Pharmaceuticals Supply Agency | ||||||
| Title: | Effective date : 13/09/2019 | |||||
| Reasons for Rejection | Rev. No.: 0 | Page 1 of 1 | ||||
| Tender no: ICB/FW/EPSA6/GF-HAPCO/NFMIII/ARV/OI/PH/03/22 | ||||||
| Item No | Product Description | Name of competitor suppliers | Status | Reason of unsuccessfulness | Remark | |
| 1 | Abacavir (ABC) – 300mg – Tablet | Victory Global Pharma FZC | Unsuccessful | Price incompetence | ||
| 4 | Atazanavir (ATV) + Ritonavir (RTV) – (300mg +100mg) – Tablet | Lupin Ltd | Unsuccessful | Was not Not in GF latest version of prequalification of ARV manufacturer/ supplier list before bid openinig | ||
| 9 | Efavirenz (EFV) – 600mg – Tablet | Victory Global Pharma FZC | Unsuccessful | Price incompetence | ||
| Aurobindo Pharma Limited | Unsuccessful | Price incompetence | ||||
| Macleods Pharmaceuticals Ltd | Unsuccessful | Price incompetence | ||||
| 11 | Lamivudine (3TC) + Dolutegravir (DTG) + Tenofovir (TDF) – (300mg + 50mg + 300mg) – Tablet | Celltrion Inc | Unsuccessful | Submited bid bond was not counter guaranted (swfit message) | ||
| Emcure Pharmaceuticals LTD | Unsuccessful | Price incompetence | ||||
| APL Healthcare Limited | Unsuccessful | Was not Not in GF latest version of prequalification of ARV manufacturer/ supplier list before bid openinig | ||||
| Cipla Limited | Unsuccessful | Price incompetence | ||||
| Lupin Ltd | Unsuccessful | Price incompetence | ||||
| Shanghai Desano Bio-pharmaceutical Co.Ltd | Unsuccessful | Price incompetence | ||||
| Victory Global Pharma FZC | Unsuccessful | Price incompetence | ||||
| 12 | Lamivudine + Tenofovir – (300mg + 300mg) – Tablet | Cipla Limited | Unsuccessful | Price incompetence | ||
| Lupin Ltd | Unsuccessful | Price incompetence | ||||
| 14 | Lamivudine + Zidovudine – (30mg + 60mg) – Tablet | Cipla Limited | Unsuccessful | Price incompetence | ||
| 15 | Lopinavir + Ritonavir – (100mg + 25mg) – Tablet | Cancelled | ||||
| 16 | Lopinavir + Ritonavir – (200mg + 50mg) – Tablet | Cipla Limited | Unsuccessful | Price incompetence | ||
| Hetro Labs Limited | Unsuccessful | Price incompetence | ||||
| Macleods Pharmaceuticals Ltd | Unsuccessful | Price incompetence | ||||
| 20 | Sulphamethoxazole + Trimethoprim – (200mg + 40mg)/5ml – Suspension | Macleods Pharmaceutical Ltd | Unsuccessful | Price incompetence | ||
| Milan Laboratories | Unsuccessful | EFDA registration certificate and SRA certificate were not submitted | ||||
| 22 | Sulphamethoxazole + Trimethoprim – (800 mg + 160 mg) – Tablet | Micro Labs Limited | Unsuccessful | EFDA registration certificate ,SRA and GMP certificate were not submitted | ||
| እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | OF for Reasons for Rejection OF/TM/HO-15, 0, 13/09/2019 | |||||
| Make sure that this is the correct issue before use | ||||||
Reasons for Rejection in prelimenary evaluation
|
|
Company Name: | Document No: OF/TM/ HO-17 | |||
| የኢትዮጵያ መድሃኒት አቅራቢ ኤጀንሲ | |||||
| Ethiopian Pharmaceuticals Supply Agency | |||||
| Title: | Effective date : 13/09/2019 | ||||
| Reasons for Rejection in prelimenary evaluation | Rev. No.: 0 | Page 1 of 1 | |||
| Tender no: ICB/FW/EPSA6/GF-HAPCO/NFMIII/ARV/OI/PH/03/22 | |||||
| S.r no | Name of competitor suppliers | Status | Reason of unsuccessfulness | Remark | |
| 1 | Mylan Laboratories Limited | Unsuccessful | By administration decision in relation with conflict of interest | ||
| እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | OF for Rejection in prelimenary evaluation OF/TM/HO-15, 0, 13/09/2019 | ||||
| Make sure that this is the correct issue before use | |||||